HOME >> BIOLOGY >> NEWS
UCSF study finds danger in marathon runners drinking too much water

Drinking too much water while running a marathon can kill you. That may sound like a rumor passed around on the Internet, but it does happen in some cases. Now researchers at the University of California, San Francisco think they know why. The excess water can help to cause the brain to swell, and fluid to leak into the lungs, either of which can be fatal. They confirm that the cure is a simple intravenous dose of salt water. The findings are published in the May 2 issue of the Archives of Internal Medicine.

Although marathon runners need to keep hydrated, in the last decade physicians have come to realize that a few hours of sweating away water and salt, but drinking only water, could put some runners into a danger zone known as hyponatremia. It was found that some runners who collapsed and died during a marathon had lost the normally well-balanced ratios of salt and water -- they had plenty of water, but far too little salt.

To understand how this might kill some runners, Allen Arieff, MD, a UCSF professor of medicine at the Veterans Affairs Medical Center in San Francisco, and two colleagues at Baylor College of Medicine, treated, or consulted on the cases of, seven athletes who suffered hyponatremia while running a marathon. They had all been nauseous, vomiting, or confused at some point during their run. Six of the seven patients survived after intravenous treatment with a high salt solution.

All the patients share several characteristics, which provide clues about the mechanisms of hyponatremia, Arieff said. In addition to having fluid in their lungs -- a hallmark of hyponatremia -- the patients all had low levels of sodium and oxygen in their blood. X-rays of six of the patients showed that they had significant brain swelling.

In the study, Arieff suggests the following mechanism. The body, in an attempt to keep a balance of salt and water levels between the blood and tissues, begins to draw water out of the blood, leading
'"/>

Contact: Kevin Boyd
kboyd@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
1-May-2000


Page: 1 2 3

Related biology news :

1. Student science contest participation influences study, career choices, alumni say
2. New study shows hope for treating inhalant abuse
3. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
4. Cigarette smoke causes breaks in DNA and defects to a cells chromosomes, Pitt study finds
5. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
6. Phase II trials of second-generation antisense cancer drug planned following successful early study
7. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
8. Indiana University, EPA to study airborne PCBs
9. K-State, other universities to study how climate affects plant evolution
10. USC study links historical increases in life span to lower childhood exposure to infection
11. Washington University in St. Louis leads group studying aging process

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: UCSF study finds danger marathon runners drinking too much water

(Date:7/31/2014)... brown and beige adipocytes, or fat cells, are inherently ... and each plays its own role in metabolism. In ... the most prevalent. Its primary function is energy storage. ... to generate heat but are only found in a ... which represent a special type of brown adipocytes, appear ...
(Date:7/30/2014)... University is paving the way for a breakthrough ... military troops exposed to poisonous chemicalsparticularly those in ... in the current issue of the journal ... which are compounds commonly used in pesticides and ... NYU School of Engineering Associate Professor of Chemical ...
(Date:7/30/2014)... change on the world,s animal and plant species ... a new paper by a research team from ... other organizations. The authors claim that most of ... it comes to climate change. , While ... the "direct" threats of changing temperatures and precipitation ...
Breaking Biology News(10 mins):Hope for the overweight 2Engineering a protein to prevent brain damage from toxic agents 2Conservation scientists asking wrong questions on climate change impacts on wildlife 2
(Date:7/31/2014)... 31, 2014   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues, today ... results will be released on Thursday, August 7, 2014, ... and live webcast at 4:30 p.m. ET that afternoon. ...
(Date:7/31/2014)... Boston’s Adult Stem Cell Technology Center, LLC ( ... cell biotechnologies. Currently the company holds seven recently ... applications currently under examination by the U.S. Patent and ... the most vexing problems in adult stem cell biology ... difficult to identify; and they have been difficult to ...
(Date:7/30/2014)... and PARIS , July 30, ... (EURONEXT: SAN and NYSE: SNY) today announced that the ... Administration (FDA) rare pediatric disease priority review voucher in ... alirocumab.  The priority review voucher entitles the holder to ... an expedited 6-month review from the filing date instead ...
(Date:7/30/2014)... 30, 2014 A study presented at ... and efficacy of CSL Behring,s C1 Inhibitor (C1-INH) ... in highly sensitized patients. C1-INH is a human ... system. The study shows that post-transplant ... the levels of complement components 3 and 4, ...
Breaking Biology Technology:BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 2The Adult Stem Cell Technology Center, LLC Launches A Marketing Campaign To License Adult Stem Cell Biotechnologies 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 2Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 3Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 4Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 5Regeneron and Sanofi Announce Plan to Use Priority Review Voucher For Alirocumab U.S. FDA Submission 6Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3
Cached News: